Published in Biochim Biophys Acta on April 19, 2006
Redox regulation in cancer: a double-edged sword with therapeutic potential. Oxid Med Cell Longev (2010) 1.99
Development and evolution of therapies targeted to the estrogen receptor for the treatment and prevention of breast cancer. Steroids (2006) 1.89
The molecular etiology of breast cancer: evidence from biomarkers of risk. Int J Cancer (2008) 1.62
Potential mechanisms of estrogen quinone carcinogenesis. Chem Res Toxicol (2007) 1.56
Estrogen treatment induces MLL aberrations in human lymphoblastoid cells. Leuk Res (2009) 1.48
Microbiome and malignancy. Cell Host Microbe (2011) 1.45
Urinary estrogens and estrogen metabolites and subsequent risk of breast cancer among premenopausal women. Cancer Res (2011) 1.28
Resveratrol prevents estrogen-DNA adduct formation and neoplastic transformation in MCF-10F cells. Cancer Prev Res (Phila) (2008) 1.26
Evidence from ESI-MS for NQO1-catalyzed reduction of estrogen ortho-quinones. Free Radic Biol Med (2007) 1.23
Relationship of serum estrogens and estrogen metabolites to postmenopausal breast cancer risk: a nested case-control study. Breast Cancer Res (2013) 1.21
Requirement for estrogen receptor alpha in a mouse model for human papillomavirus-associated cervical cancer. Cancer Res (2008) 1.21
Urine biomarkers of risk in the molecular etiology of breast cancer. Breast Cancer (Auckl) (2009) 1.21
Depurinating estrogen-DNA adducts in the etiology and prevention of breast and other human cancers. Future Oncol (2010) 1.18
Estrogen inhibits ATR signaling to cell cycle checkpoints and DNA repair. Mol Biol Cell (2009) 1.17
Estrogen metabolism and formation of estrogen-DNA adducts in estradiol-treated MCF-10F cells. The effects of 2,3,7,8-tetrachlorodibenzo-p-dioxin induction and catechol-O-methyltransferase inhibition. J Steroid Biochem Mol Biol (2007) 1.16
Estrogen metabolism and breast cancer risk among postmenopausal women: a case-cohort study within B~FIT. Carcinogenesis (2013) 1.13
Estrogen-induced breast cancer: alterations in breast morphology and oxidative stress as a function of estrogen exposure. Toxicol Appl Pharmacol (2008) 1.12
Prevention of estrogen-DNA adduct formation in MCF-10F cells by resveratrol. Free Radic Biol Med (2008) 1.10
Evidence for NQO2-mediated reduction of the carcinogenic estrogen ortho-quinones. Free Radic Biol Med (2008) 1.10
Redox cycling of catechol estrogens generating apurinic/apyrimidinic sites and 8-oxo-deoxyguanosine via reactive oxygen species differentiates equine and human estrogens. Chem Res Toxicol (2010) 1.07
Novel biomarkers for risk of prostate cancer: results from a case-control study. Prostate (2009) 1.05
Vitamin C and alpha-naphthoflavone prevent estrogen-induced mammary tumors and decrease oxidative stress in female ACI rats. Carcinogenesis (2009) 1.02
Phytoestrogens and breast cancer prevention: possible mechanisms of action. Environ Health Perspect (2008) 1.02
Breast cancer risk reduction and membrane-bound catechol O-methyltransferase genetic polymorphisms. Cancer Res (2008) 1.02
Sex steroids and prostate carcinogenesis: integrated, multifactorial working hypothesis. Ann N Y Acad Sci (2006) 1.02
CYP1B1 expression in ovarian cancer in the laying hen Gallusdomesticus. Gynecol Oncol (2008) 1.01
Inhibition of catechol-O-methyltransferase increases estrogen-DNA adduct formation. Free Radic Biol Med (2007) 1.01
Estrogen Receptor {alpha} Enhances the Rate of Oxidative DNA Damage by Targeting an Equine Estrogen Catechol Metabolite to the Nucleus. J Biol Chem (2009) 0.99
Fat/fiber intakes and sex hormones in healthy premenopausal women in USA. J Steroid Biochem Mol Biol (2008) 0.97
Urinary estrogen metabolites and self-reported infertility in women infected with Schistosoma haematobium. PLoS One (2014) 0.97
The molecular etiology and prevention of estrogen-initiated cancers: Ockham's Razor: Pluralitas non est ponenda sine necessitate. Plurality should not be posited without necessity. Mol Aspects Med (2013) 0.96
Reduction of estrogen-induced transformation of mouse mammary epithelial cells by N-acetylcysteine. J Steroid Biochem Mol Biol (2007) 0.96
Partial inhibition of estrogen-induced mammary carcinogenesis in rats by tamoxifen: balance between oxidant stress and estrogen responsiveness. PLoS One (2011) 0.96
Unexpected hormonal activity of a catechol equine estrogen metabolite reveals reversible glutathione conjugation. Chem Res Toxicol (2010) 0.95
Mechanism of metabolic activation and DNA adduct formation by the human carcinogen diethylstilbestrol: the defining link to natural estrogens. Int J Cancer (2009) 0.95
Expression levels of estrogen receptor beta in conjunction with aromatase predict survival in non-small cell lung cancer. Lung Cancer (2011) 0.94
Antioxidant butylated hydroxyanisole inhibits estrogen-induced breast carcinogenesis in female ACI rats. J Biochem Mol Toxicol (2009) 0.94
The Intestinal Microbiome and Estrogen Receptor-Positive Female Breast Cancer. J Natl Cancer Inst (2016) 0.94
BRCA1 deficiency exacerbates estrogen-induced DNA damage and genomic instability. Cancer Res (2014) 0.93
Catechol metabolites of endogenous estrogens induce redox cycling and generate reactive oxygen species in breast epithelial cells. Carcinogenesis (2011) 0.93
The watershed as a conceptual framework for the study of environmental and human health. Environ Health Insights (2009) 0.93
Resveratrol and N-acetylcysteine block the cancer-initiating step in MCF-10F cells. Free Radic Biol Med (2010) 0.92
An update on antitumor activity of naturally occurring chalcones. Evid Based Complement Alternat Med (2013) 0.92
Urinary biomarkers suggest that estrogen-DNA adducts may play a role in the aetiology of non-Hodgkin lymphoma. Biomarkers (2009) 0.91
Loss of miR-10a activates lpo and collaborates with activated Wnt signaling in inducing intestinal neoplasia in female mice. PLoS Genet (2013) 0.91
Morphologic transformation of human breast epithelial cells MCF-10A: dependence on an oxidative microenvironment and estrogen/epidermal growth factor receptors. Cancer Cell Int (2010) 0.91
Evaluation of serum estrogen-DNA adducts as potential biomarkers for breast cancer risk. J Steroid Biochem Mol Biol (2012) 0.91
Effects of estrogen on breast cancer development: Role of estrogen receptor independent mechanisms. Int J Cancer (2010) 0.90
Aggressive mammary carcinoma progression in Nrf2 knockout mice treated with 7,12-dimethylbenz[a]anthracene. BMC Cancer (2010) 0.90
Estrogen metabolite ratio: Is the 2-hydroxyestrone to 16α-hydroxyestrone ratio predictive for breast cancer? Int J Womens Health (2011) 0.88
Preferential induction of cytochrome P450 1A1 over cytochrome P450 1B1 in human breast epithelial cells following exposure to quercetin. J Steroid Biochem Mol Biol (2008) 0.88
Mechanism of DNA depurination by carcinogens in relation to cancer initiation. IUBMB Life (2011) 0.88
Chronic oxidative stress increases growth and tumorigenic potential of MCF-7 breast cancer cells. PLoS One (2014) 0.88
hPMC2 is required for recruiting an ERbeta coactivator complex to mediate transcriptional upregulation of NQO1 and protection against oxidative DNA damage by tamoxifen. Oncogene (2008) 0.88
Ultrasensitive quantification of serum estrogens in postmenopausal women and older men by liquid chromatography-tandem mass spectrometry. Steroids (2015) 0.85
Potential utility of natural products as regulators of breast cancer-associated aromatase promoters. Reprod Biol Endocrinol (2011) 0.85
N-acetylcysteine blocks formation of cancer-initiating estrogen-DNA adducts in cells. Free Radic Biol Med (2010) 0.84
Expression and DNA methylation changes in human breast epithelial cells after bisphenol A exposure. Int J Oncol (2012) 0.84
Dietary intake and serum levels of iron in relation to oxidative stress in breast cancer patients. J Clin Biochem Nutr (2009) 0.84
Reduced formation of depurinating estrogen-DNA adducts by sulforaphane or KEAP1 disruption in human mammary epithelial MCF-10A cells. Carcinogenesis (2013) 0.83
The etiology and prevention of breast cancer. Drug Discov Today Dis Mech (2012) 0.83
Dietary γ-Tocopherol-Rich Mixture Inhibits Estrogen-Induced Mammary Tumorigenesis by Modulating Estrogen Metabolism, Antioxidant Response, and PPARγ. Cancer Prev Res (Phila) (2015) 0.83
Formation of two novel estrogen guanine adducts and HPLC/MS detection of 4-hydroxyestradiol-N7-guanine in human urine. Chem Res Toxicol (2008) 0.82
Soy intake is associated with increased 2-hydroxylation and decreased 16alpha-hydroxylation of estrogens in Asian-American women. Cancer Epidemiol Biomarkers Prev (2009) 0.82
Tamoxifen resistance in breast cancer. Biomol Ther (Seoul) (2012) 0.81
Src supports UDP-glucuronosyltransferase-2B7 detoxification of catechol estrogens associated with breast cancer. Biochem Biophys Res Commun (2009) 0.81
CYP1A1 is overexpressed upon incubation of breast cancer cells with a polyphenolic cocoa extract. Eur J Nutr (2011) 0.81
CYP1B1 is not a major determinant of the disposition of aromatase inhibitors in epithelial cells of invasive ductal carcinoma. Drug Metab Dispos (2008) 0.81
Benzene and dopamine catechol quinones could initiate cancer or neurogenic disease. Free Radic Biol Med (2009) 0.81
Tocopherols inhibit oxidative and nitrosative stress in estrogen-induced early mammary hyperplasia in ACI rats. Mol Carcinog (2014) 0.81
Sulforaphane and Other Nutrigenomic Nrf2 Activators: Can the Clinician's Expectation Be Matched by the Reality? Oxid Med Cell Longev (2016) 0.80
The DNA2 nuclease/helicase is an estrogen-dependent gene mutated in breast and ovarian cancers. Oncotarget (2014) 0.80
Stability of 15 estrogens and estrogen metabolites in urine samples under processing and storage conditions typically used in epidemiologic studies. Int J Biol Markers (2010) 0.80
Expression analyses of nuclear receptor genes in breast cancer cell lines exposed to soy phytoestrogens after BRCA2 knockdown by TaqMan Low-Density Array (TLDA). J Mol Signal (2009) 0.80
Formation of diethylstilbestrol-DNA adducts in human breast epithelial cells and inhibition by resveratrol. J Steroid Biochem Mol Biol (2011) 0.79
Regulated phosphorylation of a major UDP-glucuronosyltransferase isozyme by tyrosine kinases dictates endogenous substrate selection for detoxification. J Biol Chem (2010) 0.79
Associations between Dietary Intake of Fruits and Vegetables in relation to Urinary Estrogen DNA Adduct Ratio. Open J Prev Med (2014) 0.79
Expression of the aryl hydrocarbon receptor is not required for the proliferation, migration, invasion, or estrogen-dependent tumorigenesis of MCF-7 breast cancer cells. Mol Carcinog (2012) 0.79
Tetra-methoxystilbene modulates ductal growth of the developing murine mammary gland. Breast Cancer Res Treat (2010) 0.79
XIII International Charles Heidelberger Symposium and 50 Years of Fluoropyrimidines in Cancer Therapy Held on september 6 to 8, 2007 at New York University Cancer Institute, Smilow Conference Center. Mol Cancer Ther (2009) 0.79
Modulation of nuclear receptor function by cellular redox poise. J Inorg Biochem (2014) 0.79
Inhibition of ERβ induces resistance to cisplatin by enhancing Rad51-mediated DNA repair in human medulloblastoma cell lines. PLoS One (2012) 0.79
Progesterone regulates catechol-O-methyl transferase gene expression in breast cancer cells: distinct effect of progesterone receptor isoforms. J Steroid Biochem Mol Biol (2007) 0.79
Structural determinant of chemical reactivity and potential health effects of quinones from natural products. Chem Res Toxicol (2011) 0.78
Serum Estrogens and Estrogen Metabolites and Endometrial Cancer Risk among Postmenopausal Women. Cancer Epidemiol Biomarkers Prev (2016) 0.78
Quinone Methide Bioactivation Pathway: Contribution to Toxicity and/or Cytoprotection? Curr Org Chem (2014) 0.78
Imbalanced estrogen metabolism in the brain: possible relevance to the etiology of Parkinson's disease. Biomarkers (2011) 0.78
Estrogens and Their Genotoxic Metabolites Are Increased in Obese Prepubertal Girls. J Clin Endocrinol Metab (2015) 0.78
Alcohol drinking and mammary cancer: Pathogenesis and potential dietary preventive alternatives. World J Clin Oncol (2014) 0.78
The exonuclease activity of hPMC2 is required for transcriptional regulation of the QR gene and repair of estrogen-induced abasic sites. Oncogene (2011) 0.78
Aromatase expression and regulation in breast and endometrial cancer. J Mol Endocrinol (2016) 0.77
Exploring estrogenic activity in lung cancer. Mol Biol Rep (2016) 0.77
Association of Active and Sedentary Behaviors with Postmenopausal Estrogen Metabolism. Med Sci Sports Exerc (2016) 0.77
Ultra-high sensitivity analysis of estrogens for special populations in serum and plasma by liquid chromatography-mass spectrometry: Assay considerations and suggested practices. J Steroid Biochem Mol Biol (2016) 0.77
Metabolomic profiling unravels DNA adducts in human breast that are formed from peroxidase mediated activation of estrogens to quinone methides. PLoS One (2013) 0.77
Measurement of serum estrogen and estrogen metabolites in pre- and postmenopausal women with osteoarthritis using high-performance liquid chromatography-electrospray ionization-tandem mass spectrometry. Braz J Med Biol Res (2014) 0.77
Image-based evaluation of the molecular events underlying HC11 mammary epithelial cell differentiation. Anal Biochem (2008) 0.77
Selective estrogen receptor modulator (SERM) lasofoxifene forms reactive quinones similar to estradiol. Chem Res Toxicol (2012) 0.77
4-Hydroxyestradiol induces mammary epithelial cell transformation through Nrf2-mediated heme oxygenase-1 overexpression. Oncotarget (2017) 0.76
Diallyl sulfide inhibits diethylstilbestrol induced DNA damage in human breast epithelial cells (MCF-10A). Steroids (2014) 0.76
The consensus coding sequence (CCDS) project: Identifying a common protein-coding gene set for the human and mouse genomes. Genome Res (2009) 14.90
SATB1 reprogrammes gene expression to promote breast tumour growth and metastasis. Nature (2008) 4.27
Variation analysis and gene annotation of eight MHC haplotypes: the MHC Haplotype Project. Immunogenetics (2008) 4.25
Exposure to traffic emissions throughout life and risk of breast cancer: the Western New York Exposures and Breast Cancer (WEB) study. Cancer Causes Control (2007) 2.08
Critical assessment of new risk factors for breast cancer: considerations for development of an improved risk prediction model. Endocr Relat Cancer (2007) 2.01
Sex hormone levels, breast cancer risk, and cancer receptor status in postmenopausal women: the ORDET cohort. Cancer Epidemiol Biomarkers Prev (2009) 1.99
Relationship of alcohol drinking pattern to risk of hypertension: a population-based study. Hypertension (2004) 1.97
Bone density and structure in healthy postmenopausal women treated with exemestane for the primary prevention of breast cancer: a nested substudy of the MAP.3 randomised controlled trial. Lancet Oncol (2012) 1.94
Breast carcinoma malignancy grading by Bloom-Richardson system vs proliferation index: reproducibility of grade and advantages of proliferation index. Mod Pathol (2005) 1.94
Relation between lung function and RBC distribution width in a population-based study. Chest (2003) 1.83
DNA sequence of human chromosome 17 and analysis of rearrangement in the human lineage. Nature (2006) 1.81
In utero exposure to bisphenol A shifts the window of susceptibility for mammary carcinogenesis in the rat. Environ Health Perspect (2010) 1.75
Pulmonary function and abdominal adiposity in the general population. Chest (2006) 1.74
Drinking pattern and risk of non-fatal myocardial infarction: a population-based case-control study. Addiction (2004) 1.71
Outcome of patients with early-stage breast cancer treated with doxorubicin-based adjuvant chemotherapy as a function of HER2 and TOP2A status. J Clin Oncol (2009) 1.67
The greater reactivity of estradiol-3,4-quinone vs estradiol-2,3-quinone with DNA in the formation of depurinating adducts: implications for tumor-initiating activity. Chem Res Toxicol (2006) 1.65
The molecular etiology of breast cancer: evidence from biomarkers of risk. Int J Cancer (2008) 1.62
Phase I trial evaluating the concurrent combination of radiotherapy and capecitabine in rectal cancer. J Clin Oncol (2002) 1.54
Circulating levels of sex steroid hormones and risk of endometrial cancer in postmenopausal women. Int J Cancer (2004) 1.52
Lifetime cumulative exposure to secondhand smoke and risk of myocardial infarction in never smokers: results from the Western New York health study, 1995-2001. Arch Intern Med (2006) 1.51
Low-molecular-weight heparin vs unfractionated heparin for perioperative thromboprophylaxis in patients with cancer: a systematic review and meta-analysis. Arch Intern Med (2008) 1.51
Soluble fragment of P-cadherin adhesion protein found in human milk. J Cell Biochem (2002) 1.48
An evaluation of the integration of non-traditional learning tools into a community based breast and cervical cancer education program: the Witness Project of Buffalo. BMC Cancer (2003) 1.48
Myocardial injury after noncardiac surgery: a large, international, prospective cohort study establishing diagnostic criteria, characteristics, predictors, and 30-day outcomes. Anesthesiology (2014) 1.47
Dysregulation of glucose transport, glycolysis, TCA cycle and glutaminolysis by oncogenes and tumor suppressors in cancer cells. Biochim Biophys Acta (2012) 1.44
Circulating inflammation markers and risk of epithelial ovarian cancer. Cancer Epidemiol Biomarkers Prev (2011) 1.44
Alcohol drinking pattern and subjective health in a population-based study. Addiction (2006) 1.43
Metformin elicits anticancer effects through the sequential modulation of DICER and c-MYC. Nat Commun (2012) 1.41
Reducing cancer disparities for minorities: a multidisciplinary research agenda to improve patient access to health systems, clinical trials, and effective cancer therapy. J Clin Oncol (2006) 1.41
ERalpha-negative and triple negative breast cancer: molecular features and potential therapeutic approaches. Biochim Biophys Acta (2009) 1.41
Low molecular weight heparin versus unfractionated heparin for perioperative thromboprophylaxis in patients with cancer. Cochrane Database Syst Rev (2014) 1.40
Hyperquenched glassy water and hyperquenched glassy ethanol probed by single molecule spectroscopy. J Phys Chem B (2009) 1.39
The execution of the transcriptional axis mutant p53, E2F1 and ID4 promotes tumor neo-angiogenesis. Nat Struct Mol Biol (2009) 1.39
Oral exposure to bisphenol a increases dimethylbenzanthracene-induced mammary cancer in rats. Environ Health Perspect (2009) 1.38
Urinary 6-sulfatoxymelatonin levels and risk of breast cancer in postmenopausal women. J Natl Cancer Inst (2008) 1.37
Breast cancer risk and exposure in early life to polycyclic aromatic hydrocarbons using total suspended particulates as a proxy measure. Cancer Epidemiol Biomarkers Prev (2005) 1.34
MMTV Env encodes an ITAM responsible for transformation of mammary epithelial cells in three-dimensional culture. J Exp Med (2005) 1.34
Body fat distribution, relative weight, and liver enzyme levels: a population-based study. Hepatology (2004) 1.33
Prediagnostic levels of C-peptide, IGF-I, IGFBP -1, -2 and -3 and risk of endometrial cancer. Int J Cancer (2004) 1.33
Lifetime adult weight gain, central adiposity, and the risk of pre- and postmenopausal breast cancer in the Western New York exposures and breast cancer study. Int J Cancer (2006) 1.29
Mammosphere-forming cells from breast cancer cell lines as a tool for the identification of CSC-like- and early progenitor-targeting drugs. Cell Cycle (2010) 1.28
Circulating levels of insulin-like growth factor-I and risk of ovarian cancer. Int J Cancer (2002) 1.24
Epithelial to mesenchymal transition in human breast epithelial cells transformed by 17beta-estradiol. Cancer Res (2007) 1.23
Serum iron, copper and zinc concentrations and risk of cancer mortality in US adults. Ann Epidemiol (2004) 1.22
Estradiol and its metabolites 4-hydroxyestradiol and 2-hydroxyestradiol induce mutations in human breast epithelial cells. Int J Cancer (2006) 1.22
Endogenous sex hormones and subsequent breast cancer in premenopausal women. Int J Cancer (2004) 1.21
Dietary patterns related to glycemic index and load and risk of premenopausal and postmenopausal breast cancer in the Western New York Exposure and Breast Cancer Study. Am J Clin Nutr (2007) 1.21
Sodium/potassium ATPase (Na+, K+-ATPase) and ouabain/related cardiac glycosides: A new paradigm for development of anti- breast cancer drugs? Breast Cancer Res Treat (2005) 1.21
Urinary 6-Sulphatoxymelatonin levels and risk of breast cancer in premenopausal women: the ORDET cohort. Cancer Epidemiol Biomarkers Prev (2010) 1.20
Identification of cripto-1 as a novel serologic marker for breast and colon cancer. Clin Cancer Res (2006) 1.18
Estrogen-mediated epigenetic repression of large chromosomal regions through DNA looping. Genome Res (2010) 1.18
Regulation of energy metabolism pathways by estrogens and estrogenic chemicals and potential implications in obesity associated with increased exposure to endocrine disruptors. Biochim Biophys Acta (2009) 1.17
Circulating levels of sex steroid hormones and risk of ovarian cancer. Int J Cancer (2003) 1.17
Catechol quinones of estrogens in the initiation of breast, prostate, and other human cancers: keynote lecture. Ann N Y Acad Sci (2006) 1.16
A randomised controlled trial of a care home rehabilitation service to reduce long-term institutionalisation for elderly people. Age Ageing (2004) 1.15
miR-10b*, a master inhibitor of the cell cycle, is down-regulated in human breast tumours. EMBO Mol Med (2012) 1.14
Dietary patterns and risk of breast cancer in the ORDET cohort. Cancer Epidemiol Biomarkers Prev (2004) 1.14
Pharmacologic optimization of protease inhibitors and nonnucleoside reverse transcriptase inhibitors (POPIN)--a randomized controlled trial of therapeutic drug monitoring and adherence support. J Acquir Immune Defic Syndr (2006) 1.14
Synthesis of the catechols of natural and synthetic estrogens by using 2-iodoxybenzoic acid (IBX) as the oxidizing agent. Steroids (2005) 1.13
Effect of prenatal exposure to the endocrine disruptor bisphenol A on mammary gland morphology and gene expression signature. J Endocrinol (2008) 1.12
The estrogen antagonist ICI-182-780 does not inhibit the transformation phenotypes induced by 17-beta-estradiol and 4-OH estradiol in human breast epithelial cells. Int J Oncol (2005) 1.12
Pregnancy-induced changes in breast cancer risk. J Mammary Gland Biol Neoplasia (2011) 1.11
Differential effects of alcohol drinking pattern on liver enzymes in men and women. Alcohol Clin Exp Res (2004) 1.10
Dietary glycemic index, glycemic load, and the risk of breast cancer in an Italian prospective cohort study. Am J Clin Nutr (2007) 1.10
Geographic clustering of residence in early life and subsequent risk of breast cancer (United States). Cancer Causes Control (2004) 1.10
A prospective study of dietary selenium intake and risk of type 2 diabetes. BMC Public Health (2010) 1.09
GRADE: assessing the quality of evidence for diagnostic recommendations. Evid Based Med (2008) 1.08
MYC is activated by USP2a-mediated modulation of microRNAs in prostate cancer. Cancer Discov (2012) 1.07
Genomic anatomy of the Tyrp1 (brown) deletion complex. Proc Natl Acad Sci U S A (2006) 1.07
Effects of assessing the productivity of faculty in academic medical centres: a systematic review. CMAJ (2012) 1.06
Novel biomarkers for risk of prostate cancer: results from a case-control study. Prostate (2009) 1.05
Epithelial mesenchymal transition during the neoplastic transformation of human breast epithelial cells by estrogen. Int J Oncol (2007) 1.05
Genomic signature induced by pregnancy in the human breast. Int J Oncol (2006) 1.04
Benefits and drawbacks of including consumer reviewers in the scientific merit review of breast cancer research. J Womens Health Gend Based Med (2002) 1.04
MHC-linked and un-linked class I genes in the wallaby. BMC Genomics (2009) 1.04
Estrogen mediation of breast tumor formation involves estrogen receptor-dependent, as well as independent, genotoxic effects. Ann N Y Acad Sci (2009) 1.04
Prospective study on the role of glucose metabolism in breast cancer occurrence. Int J Cancer (2011) 1.03
Alcohol drinking patterns differentially affect central adiposity as measured by abdominal height in women and men. J Nutr (2003) 1.03
Assessing spatio-temporal variability of risk surfaces using residential history data in a case control study of breast cancer. Int J Health Geogr (2005) 1.03
Breast cancer risk reduction and membrane-bound catechol O-methyltransferase genetic polymorphisms. Cancer Res (2008) 1.02
Accuracy and biological variation of human serum paraoxonase 1 activity and polymorphism (Q192R) by kinetic enzyme assay. Clin Chem (2006) 1.01
Inhibition of catechol-O-methyltransferase increases estrogen-DNA adduct formation. Free Radic Biol Med (2007) 1.01
Formation of depurinating N3Adenine and N7Guanine adducts by MCF-10F cells cultured in the presence of 4-hydroxyestradiol. Int J Cancer (2007) 1.00
Exposure to the Endocrine Disruptor Bisphenol A Alters Susceptibility for Mammary Cancer. Horm Mol Biol Clin Investig (2011) 1.00
17 beta -estradiol-mediated vessel assembly and stabilization in tumor angiogenesis requires TGF beta and EGFR crosstalk. Angiogenesis (2003) 1.00
Magnitude of benefit of the addition of bevacizumab to first-line chemotherapy for metastatic colorectal cancer: meta-analysis of randomized clinical trials. J Exp Clin Cancer Res (2010) 1.00
Low-molecular-weight heparins are superior to vitamin K antagonists for the long term treatment of venous thromboembolism in patients with cancer: a cochrane systematic review. J Exp Clin Cancer Res (2008) 0.99
Regulation of mitochondrial respiratory chain structure and function by estrogens/estrogen receptors and potential physiological/pathophysiological implications. Biochim Biophys Acta (2005) 0.99
Erythrocyte membrane phospholipid composition as a biomarker of dietary fat. Ann Nutr Metab (2005) 0.99
Dietary lignan intakes and risk of pre- and postmenopausal breast cancer. Int J Cancer (2004) 0.99
Lung function in relation to intake of carotenoids and other antioxidant vitamins in a population-based study. Am J Epidemiol (2002) 0.98
Serum testosterone levels and breast cancer recurrence. Int J Cancer (2005) 0.98
Histologic changes in the breast with menopausal hormone therapy use: correlation with breast density, estrogen receptor, progesterone receptor, and proliferation indices. Menopause (2008) 0.97
Defining the genomic signature of the parous breast. BMC Med Genomics (2012) 0.97
Internet access for delivery of health information to South Australians older than 50. Aust N Z J Public Health (2008) 0.97
Is mammographic density, as currently measured, a robust surrogate marker for breast cancer? Gynecol Endocrinol (2005) 0.96